New Key Statistics Module, Z-Score and F-Score
OTCPK:XVIPF Key Ratios
| Market Cap $ M | 1,382.18 |
| Enterprise Value $ M | 1,310.00 |
| P/E(ttm) | 65.73 |
| PE Ratio without NRI | 65.73 |
| Forward PE Ratio | 74.47 |
| Price/Book | 6.98 |
| Price/Sales | 19.20 |
| Price/Free Cash Flow | 213.55 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 72.00 |
| EPS (TTM) $ | 0.64 |
| Beneish M-Score | -1.85 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 266.90 |
| EV-to-EBIT | 91.21 |
| EV-to-EBITDA | 91.21 |
| PEG | -- |
| Shares Outstanding M | 31.50 |
| Net Margin (%) | 27.21 |
| Operating Margin % | 7.72 |
| Pre-tax Margin (%) | 28.76 |
| Quick Ratio | 4.23 |
| Current Ratio | 5.49 |
| ROA % (ttm) | 9.09 |
| ROE % (ttm) | 10.23 |
| ROIC % (ttm) | 3.19 |
| Dividend Yield % | -- |
| Altman Z-Score | 44.82 |
XVIPF Number of Guru Trades
XVIPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:XVIPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:XVIPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xvivo Perfusion AB Insider Transactions
No Available Data
News about OTCPK:XVIPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers